Coinfección TB/VIH: Guía Clínica. Versión actualizada – 2010

DHHS. Guidelines for the use of antiretroviral agents in HIV-1-infected
adults and adolescents. 2009: 1–161.
Donald PR. Childhood tuberculosis. Curr Opin Pulmonary Med
2000;6:187–92.
Ebraert H, Salu P. Toxic uveitis caused by pharmacodynamic interactions
of Rifabutin and protease inhibitors: a case report. Bull Soc Belge
Ophtalmol. 2007: 57–60.
Essential prevention and care interventions for adults and adolescents
living with HIV in resource limited settings. World Health Organization.
Geneva. 2008
Farzadejan H et al. Detection of human immunodeficiency virus type
1 infection by Polymerase chain reaction in a cohort of seronegative intravenous
drug users. J. Infectious Diseases1993Aug:168(2);327–31.
Ferri F. Practical Guide to the Care of the Medical Patient. The C.V.
Mosby Company: St Louis, 1987.
Gandhi NR et al. Extensively drug-resistant tuberculosis as a cause of
death in patients co-infected with tuberculosis and HIV in a rural area
of South Africa. Lancet, 2006, 368(9547):1575–1580
Gilbert D., Moellering Jr. R., M., Eliopoulos G., Saaag M., Chambers
H. The Sanford Guide to HIV/AIDS Therapy. 2009. 17th Edition.
Antimicrobial Therapy Inc. 2008
Guía para la consejería y pruebas de VIH/sida en los programas de
control de tuberculosis.Organización Panamericana de la Salud.
Washington, DC, 2006.
151